Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features
A. L. Godfrey, P. J. Campbell, Cathy MacLean, G. Buck, J. Cook, J. Temple, B. S. Wilkins, Keith Wheatley, J. Nangalia, J. Grinfeld, M. F. McMullin, C. Forsyth, J. J. Kiladjian, A. R. Green, C. N. Harrison
Research output: Contribution to journal › Article › peer-review
17Citations
(Scopus)
327Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features'. Together they form a unique fingerprint.